U.S. Moves to Limit Chinese Biotech Firms Amid Security Concerns

Legislation aims to protect national interests by restricting companies with ties to China's military from engaging with federally funded medical providers.

• U.S. lawmakers are concerned about America's ability to compete with China in the biotechnology sector, emphasizing the potential risks to national security and commercial interests.
• Bills have been introduced in both the House and Senate aiming to restrict

3 Articles

Financial Post Newsday Associated Press